(Q35048295)

6 August 2017

Cost effect of managing methicillin-resistant Staphylococcus aureus in a long-term care facility (English)

1 reference

methicillin-resistant Staphylococcus aureus

6 August 2017

0 references

Staphylococcus aureus

1 reference

4

David P Nicolau

1 reference

6 August 2017

Blair Capitano

1

1 reference

6 August 2017

O Alice Leshem

series ordinal

2

1 reference

6 August 2017

Charles H Nightingale

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

Journal of the American Geriatrics Society

6 August 2017

1 reference

6 August 2017

51

1 reference

6 August 2017

1

1 reference

6 August 2017

10-16

1 reference

Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.

6 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-5215.2002.51003.X

Issues in the management of resistant bacteria in long-term-care facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-5215.2002.51003.X

7 January 2021

Contrasting methicillin-resistant Staphylococcus aureus colonization in Veterans Affairs and community nursing homes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-5215.2002.51003.X

7 January 2021

The economic impact of Staphylococcus aureus infection in New York City hospitals

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-5215.2002.51003.X

7 January 2021

Antibiotic-resistant organisms among long-term care facility residents on admission to an inpatient geriatrics unit: Retrospective and prospective surveillance

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-5215.2002.51003.X

7 January 2021

Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-5215.2002.51003.X

7 January 2021

Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-5215.2002.51003.X

7 January 2021

Minocycline: old and new therapeutic uses.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-5215.2002.51003.X

7 January 2021

Quinupristin-dalfopristin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-5215.2002.51003.X

7 January 2021

10.1034/J.1601-5215.2002.51003.X

Identifiers

DOI

1 reference

6 August 2017

1 reference